Literature DB >> 10437614

Primary liver disease as a determinant for acute rejection after liver transplantation.

C A Seiler1, J F Dufour, E L Renner, M Schilling, M W Büchler, P Bischoff, J Reichen.   

Abstract

BACKGROUND: Graft rejection and infection remain major problems following liver transplantation; both are heavily influenced by the immunosuppressive regimen. Despite the disparity in the primary disease leading to transplantation, all patients receive the same posttransplant immunosuppressive treatment in a given center. The aim of this study is to detect a possible effect of the underlying disease on the incidence of early acute rejection episodes after orthotopic liver transplantation (OLT). PATIENTS AND METHODS: Retrospective analysis on all 101 consecutive liver transplants performed in 95 patients between 1983 and March 1998; five of these patients, surviving less than 30 days, were not included. The immunosuppressive regimen was based on conventional triple therapy during the whole study period. The diagnosis and treatment of acute rejection within the first 30 days post-OLT was uniform throughout the whole study period.
RESULTS: Though there were no differences with respect to patients' characteristics [age, child classification, number of HLA-mismatches or cytomegalovirus (CMV)-serocompatibility], patients with primary biliary cirrhosis (PBC) showed a significant increase of acute rejection after OLT compared with the other patients transplanted for other liver diseases (P = 0.024). The incidence of infection was not elevated in patients transplanted for PBC when compared with other diagnoses.
CONCLUSION: Our results indicate that primary liver disease may be a determinant for acute graft rejection in PBC. Furthermore, these results suggest that immunosuppressive regimens based on the underlying disease should be considered.

Entities:  

Mesh:

Year:  1999        PMID: 10437614     DOI: 10.1007/s004230050201

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  3 in total

1.  Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation.

Authors:  Timothy M Schmitt; Melissa Phillips; Robert G Sawyer; Patrick Northup; Klaus D Hagspiel; Timothy L Pruett; Hugo J R Bonatti
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

Review 2.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

Authors:  Bjarte Fosby; Tom H Karlsen; Espen Melum
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

3.  Association of GSTO2 (N142D) Genetic Polymorphism and Acute Rejection of Liver.

Authors:  M Khosravi; I Saadat; M H Karimi; S A Malek Hosseini
Journal:  Int J Organ Transplant Med       Date:  2016-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.